Follicular Lymphoma

Fourteen months ago I profiled Biovest and the company's innovative therapeutic

Follicular lymphoma is classified as a

You've just finished six rounds of tough CHOP combination chemotherapy plus the

Today I'm very pleased to be writing about a movement to

Swiss pharmaceutical giant Roche announced on Wednesday that a late-stage study

FDA Approves Zevalin® Expanded Label as Part of First-Line Therapy in Treatment of Follicular

Autologous stem cell transplantation (SCT), when followed by a sibling reduced-intensity

Earlier this month, the biopharmaceutical company Biovest

Results of a new study could have major implications for patients with follicular

Follicular lymphoma remains an incurable subtype, and it is especially difficult to

This article looks at the survival rate for Follicular lymphoma

Determining which follicular lymphoma treatment options to go with—and when to go with them—is

Sitemap